[74] Accordingly, some clinical trials have been initiated in SLE, using monoclonal antibodies against IFN-α and its receptor (IFNAR) or using an immune therapy to induce polyclonal anti-IFN-α ...
Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a speculative buy in the market. See more here.